The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
|Articles|November 1, 2010
- Pharmaceutical Technology-11-02-2010
- Volume 34
- Issue 11
Pharmaceutical Technology, November 2010 Issue (PDF)
Solubilizing the Insoluble
Advertisement
Articles in this issue
almost 16 years ago
In the Spotlight November 2010almost 16 years ago
Formulation Development Forum: Abuse-deterrent combination drugsalmost 16 years ago
Inside USP: Adulteration and Contamination Awarenessalmost 16 years ago
Keep It Cleanalmost 16 years ago
Report from Indiaalmost 16 years ago
Solubilizing the Insolublealmost 16 years ago
Advances in Solid-State Chemistryalmost 16 years ago
Automated Inspection of Pharmaceutical Productsalmost 16 years ago
Ideas Know No Bordersalmost 16 years ago
A Common Future Requires CollaborationAdvertisement
Related to this article
Subathra Ramamoorthy, Veranova, on when to escalate to structural elucidation and pair orthogonal techniques when characterizing an impurity.
Manish Baviskar, Hubot CDMO, on ALCOA++ data integrity, model version change control, continuous monitoring, and human sign-off.
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Manish Baviskar, Hubot CDMO, explains which AI skills validation engineers need first and why AI model updates must go through GMP change control.
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF, talks about spray drying for drying amorphous solid dispersions and Raman spectroscopy’s role as a quantitative analytical tool.
Aleksandra Zuraw, senior veterinary pathologist at Charles River, discusses how chain of custody, good laboratory practice, quality control, and validation are applied to digital pathology data used in drug development.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why AI Model Updates Need Change Control: AAPS PharmSci 360 2026
2
From URS to Acceptance Evidence: Defining and Testing Interfaces in Pen Injector Assembly
3
USP 1074 Revises Excipient Safety: AAPS PharmSci 360 2026
4
AI Formulation: Regulators Want Data
5